Abacus Bioscience is developing a new class of immunotherapy that unleashes the power of a novel CD180 platform technology.
Our Antigen-Specific Immune Accelerants (ASIA) are POTENT, SPECIFIC and DURABLE, with broad applications across infectious disease and oncology.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Seattle, Wa 98109, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.abacusbioscience.com
- Keywords
- Manager jobs.
- HQ
- Seattle, WA
Abacus Bioscience Inc Questions
Abacus Bioscience Inc's website is http://www.abacusbioscience.com
Abacus Bioscience Inc's LinkedIn profile is https://www.linkedin.com/company/abacus-bioscience
Abacus Bioscience Inc has
8 employees.
View email and phone details for 8
employees at Abacus Bioscience Inc.
Abacus Bioscience Inc's industry is
Biotechnology Research
Abacus Bioscience Inc's top competitors are
Umoja Biopharma,
Monod Bio,
Phase Genomics,
Deverra Therapeutics,
Lumen Bioscience,
Mozart Therapeutics, Inc.,
Tune Therapeutics,
Shape Therapeutics Inc.,
Sonoma Biotherapeutics, Inc.,
Parse Biosciences.
Abacus Bioscience Inc's categories are Biotechnology Research
Abacus Bioscience Inc's founding year is 2017
